Fast-growing OTC platform
Sylphar is a Belgium-based company developing and marketing OTC products. Sylphar focuses on bringing innovative and consumer friendly products to the global market, with main markets including Germany, the UK, France, Spain and Italy. The product offering includes beauty products, including oral therapy and medicated skincare ranges, as well as food supplements, including vitamins and vegan nutrition products.
The company operates a multi-channel distribution strategy with a strong online presence through marketplaces, other third party platforms and its own webshop, as well as offline through pharmacies and drugstores. presence and expertise.
Vendis teamed up with founder and CEO Robin List with the ambition to accelerate the growth, both organically and through acquisitions, with a view of building one of the leading European omni-channel players in the consumer healthcare space.
Vendis Capital initially invested in Sylphar in May 2017.